Latest Conference Articles

Follow-up Results for Harmony TPV System Demonstrate Efficacy at 1-Year

Follow-up Results for Harmony TPV System Demonstrate Efficacy at 1-Year

May 2nd 2021

SCAI 2021

Results of 1-year follow-up from the Harmony TPV Clinical trial provide insight into the safety and efficacy of the recently approved Harmony TPV system in patients with congenital heart disease and severe pulmonary regurgitation.

Presentations for Acute MIs Dropped Drastically During Peak of COVID-19 Pandemic

Presentations for Acute MIs Dropped Drastically During Peak of COVID-19 Pandemic

April 30th 2021

SCAI 2021

An analysis of data from NYU Langone provides perspective into the rapid decline of emergency department presentations for acute myocardial infarction that occurred during the peak of the COVID-19 pandemic.

SCAI 2021: ISCHEMIA Represents a Fraction of Patients with SIHD Undergoing PCI

SCAI 2021: ISCHEMIA Represents a Fraction of Patients with SIHD Undergoing PCI

April 29th 2021

SCAI 2021

An analysis comparing a national registry against ISCHEMIA enrollment criteria suggests trial eligibility represents less than 2% of all patients undergoing PCI and less than a third of patients undergoing PCI with stable ischemic heart disease.

Extended-Duration DAPT Reduces Mortality, Event Rate in TWILIGHT-like Patients

Extended-Duration DAPT Reduces Mortality, Event Rate in TWILIGHT-like Patients

April 29th 2021

SCAI 2021

An SCAI 2021 analysis of more than 4k patients with characteristics similar to those included in the TWILIGHT trial indicates extended-duration DAPT, defined as a duration of more than 12 months post-PCI, was a more efficacious approach than short-term DAPT in this patient population.

Improving Patient Outcomes, Balancing Cost of Mobile Stroke Units with Louise McCullough, MD, PhD

Improving Patient Outcomes, Balancing Cost of Mobile Stroke Units with Louise McCullough, MD, PhD

March 23rd 2021

ISC 2021

Check out this interview with Louise McCullough, MD, PhD, Program Chair of ISC 21, where she offers perspective on mobile stroke units and what barriers prevent further implementation of the specialized ambulatory units.

Understanding the American Heart Association's Scientific Statement on Brain Health

Understanding the American Heart Association's Scientific Statement on Brain Health

March 20th 2021

ISC 2021

Just ahead of the International Stroke Conference, the AHA released a scientific statement focusing on brain health and aimed at providing primary care providers an overview of factors influencing neurologic health.

AHA Registry Provides Comprehensive Review of Ischemic Stroke in COVID-19 Patients

AHA Registry Provides Comprehensive Review of Ischemic Stroke in COVID-19 Patients

March 19th 2021

ISC 2021

Using data from the AHA's COVID-19 Cardiovascular Disease Registry, a new analysis presented at ISC 21 provides an overview of the overall risk, risk factors, and outcomes of COVID-19-related ischemic stroke among US patients.

Mobile Stroke Units Proving Their Worth But Limited by Reimbursement Issues

Mobile Stroke Units Proving Their Worth But Limited by Reimbursement Issues

March 18th 2021

ISC 2021

A pair of studies from ISC 21 is providing insight into the benefits of mobile stroke units while also highlighting current barriers to widespread implementation of these units.

Immediate Angiography Could Preserve Function, Improve Outcomes in LVO Stroke

Immediate Angiography Could Preserve Function, Improve Outcomes in LVO Stroke

March 17th 2021

ISC 2021

An interim analysis of the ANGIOCAT trial suggests immediate angiography could help preserve function and improve outcomes in the treatment of patients with stroke caused by a large vessel occlusion compared to the current standard of performing a CT scan.

Black Medicare Patients 4% More Likely to Die in Decade Following Stroke than White Counterparts

Black Medicare Patients 4% More Likely to Die in Decade Following Stroke than White Counterparts

March 17th 2021

ISC 2021

A study from ISC 21 suggests Black patients using Medicare were 4% more likely to die in the first 10 years after a stroke than their white counterparts.